AXXE is Set for Success

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder


SmallCapVoice Newsletter

AXXE is Set for Success ———————————————————————– Hot Stock to Watch ———————————————————————– Company: Axxess Pharma Inc. (Pink Sheets: AXXE) Close:

Price: 0.89 Change (%): + 0.01 (1.14) Volume: 51,367 http://bit.ly/17kZMWG Dr. Daniel Bagi, President and CEO of Axxess Pharma, Inc., is Featured in a New Audio Interview at SmallCapVoice.com AUSTIN, Texas, July 17, 2013 (GLOBE NEWSWIRE) – SmallCapVoice.com, Inc. announced today that a new audio interview with Axxess Pharma, Inc. (Pink Sheets: AXXE), is now available. The interview can be heard at http://smallcapvoice.com/blog/7-15-13-smallcapvoice-interview-with-axxess-pharma-inc-axxe Dr. Daniel Bagi, President and CEO of Axxess Pharma, Inc. called into SmallCapVoice.com to discuss the news for the Company, the business models and markets for their technologies, the goals for AXXE in 2013, and much more.


“We are excited about where we stand today as a Company,” explains Dr. Daniel Bagi. “We are working to sustain and increase shareholder value through executing on our accelerated growth model in 2013 and beyond.” Continue Reading – http://bit.ly/1bogF7L ———————————————————————– IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ———————————————————————– SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security.

SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com.

opt out of our distribution list at any time by clicking on the “

 

Related posts:

  1. AXXE is in Our Spotlight for Tomorrow


You may also like...